AstraZeneca to List Shares Directly on New York Stock Exchange
1. AstraZeneca plans to list ordinary shares directly on NYSE. 2. This replaces its listing of American depository receipts on Nasdaq. 3. Company remains headquartered and tax resident in the UK. 4. Move aims to align listing structure with long-term growth strategy. 5. AstraZeneca continues to be part of Sweden’s OMX Stockholm 30 index.